Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
about
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cellsFcγ receptors and ligands and cardiovascular diseasePentraxins: structure, function, and role in inflammationAssociation between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant dataEffects of antisense oligonucleotides against C-reactive protein on the development of atherosclerosis in WHHL rabbits.Animal models of C-reactive protein.Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk.Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice.Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction.Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome.Atherosclerosis-related functions of C-reactive protein.Exposing a hidden functional site of C-reactive protein by site-directed mutagenesisThe connection between C-reactive protein and atherosclerosisInflammatory mechanisms in the regulation of insulin resistance.The pro-atherogenic effects of macrophages are reduced upon formation of a complex between C-reactive protein and lysophosphatidylcholine.Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.Cross-Tissue Regulatory Gene Networks in Coronary Artery DiseasePlasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery DiseasePediatric obstructive sleep apnea: complications, management, and long-term outcomes.CCR5 deletion protects against inflammation-associated mortality in dialysis patients.Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis.Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesisC-reactive protein at the interface between innate immunity and inflammation.High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease?Recognition functions of pentameric C-reactive protein in cardiovascular diseaseC-reactive protein and inflammation: conformational changes affect function.Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modificationFunctional Transformation of C-reactive Protein by Hydrogen Peroxide.The Endothelium as a Target in Pediatric OSA.Linking inflammation and thrombosis: Role of C-reactive proteinMonomeric C-reactive protein and inflammatory injury in myocardial infarction.Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques.Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.Anti-inflammatory therapies in myocardial infarction: failures, hopes, and challenges.High-sensitivity C-reactive protein: still need for next-generation biomarkers for remote future cardiovascular events.C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases.
P2860
Q24321501-BD14A0EA-9172-43B9-8386-4EBDAC65B1DEQ27021449-F0B3B75B-8DA0-4BFA-ACBA-36129E2C9997Q28676262-7B36DAB2-631D-4EA9-B7AA-4C7B371DC6D6Q28742740-8CB05D41-CD94-4530-8B29-8E0E9FA404B7Q33607457-2FD1D92E-85B8-4121-AC28-9408033D0CF1Q33607563-92242BE7-1854-42A9-ABFF-71E5AA5D0E0FQ33679929-82A14F2F-7BBD-48E0-91EF-816F7B6424B9Q33796862-55A897C9-0D32-464B-A28E-BA444246853CQ33905741-CDAA0CDF-2605-44B1-AC86-CD744E2C57BFQ34021492-A784B725-69F6-4C85-93A1-440999503F83Q34675880-E39D75D2-A2A9-43E2-A041-B982739BDECCQ34691058-A7CC63FC-FA4A-4E0F-8705-14DECFA10010Q34698229-417B8CB0-0FB6-4B3F-9CA0-E700098B43F1Q35073552-3A5CE8DF-2E3B-4681-B740-E9C596BA4229Q35728529-EB32C158-36DB-44D1-9B0F-931D72F1D5BEQ35999439-E6818FAF-040A-4156-B3C1-FD19EE4EE9E3Q36409227-D17EB372-A125-4345-B106-B9FA51838C57Q36423484-220A21A1-BBA0-4F7F-B417-CD47415F1EE5Q36801469-E446E2BC-E64A-4303-B52F-97A6E7A0F229Q36865220-A4F01E28-17C9-4B94-968A-89E059D5BFB1Q36922192-4366D227-3475-4DE3-9BC1-4703621B8BC4Q37077182-15904FBB-D335-4943-A34D-834AE0E5591EQ37259261-0B8023A9-D168-44D2-B389-6249C95A770DQ37338146-20837ECA-DDFD-48A2-B80C-BB1DF337C657Q37406470-2EA7AED6-20C3-4EE9-B826-14A8CC2F7935Q37652507-755207A8-712A-4769-A423-C9B07BF4A282Q37754545-1FE92887-1518-4AC8-814A-875FB0B55D3EQ37980496-505565A6-A4C8-479E-99C9-17E37E92A061Q38221846-605BBEB9-3310-40DB-848E-8D5DC8879462Q38514723-E6B94C2D-179C-4244-ABE7-E6FC127A6BCFQ38584193-B40D4A75-668E-475F-9D47-CD797442AB28Q39016069-A233AD28-DD65-4B49-9192-30363C8990A6Q39602294-5A584770-4113-4FA0-80B2-B3617404412CQ41332165-0ADC91E4-3A92-4D7D-9E50-C817ABA25574Q42325772-415FFD91-6FE7-4ACF-8FD6-DD86B6A93FA7Q44069143-7C188979-E5D0-47D4-A4F6-95DF84982CF1Q48024005-8DDC98BA-470B-4076-8084-4A39A03DCA34Q48113765-C9646363-C6AD-4FD0-B44C-511278DE3AC5Q51289480-DAA1110A-D9CD-4DF7-A08A-E963233FA607Q54639844-BB7B161A-68A9-42E2-9DDC-040046780649
P2860
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@ast
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@en
type
label
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@ast
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@en
prefLabel
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@ast
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@en
P2860
P50
P356
P1476
Human C-reactive protein slows ...... uman-like hypercholesterolemia
@en
P2093
Alexander Kovacs
Johan Björkegren
P2860
P304
13768-13773
P356
10.1073/PNAS.0706027104
P407
P577
2007-08-16T00:00:00Z